NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
William Dahut
National Cancer Institute - Bethesda / United States
Others
AD Scientific Index ID: 4384445
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
William Dahut's MOST POPULAR ARTICLES
1-)
Androgen deprivation therapy for prostate cancerN Sharifi, JL Gulley, WL DahutJama 294 (2), 238-244, 200511372005
2-)
Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancerPW Kantoff, TJ Schuetz, BA Blumenstein, LM Glode, DL Bilhartz, ...Journal of Clinical Oncology 28 (7), 1099, 201011152010
3-)
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working GroupGJ Bubley, M Carducci, W Dahut, N Dawson, D Daliani, M Eisenberger, ...Journal of Clinical Oncology 17 (11), 3461-3467, 199911151999
4-)
Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysisX Zhu, S Wu, WL Dahut, CR ParikhAmerican journal of kidney diseases 49 (2), 186-193, 20077992007
5-)
Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancerWL Dahut, JL Gulley, PM Arlen, Y Liu, KM Fedenko, SM Steinberg, ...Journal of clinical oncology 22 (13), 2532-2539, 20044532004
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept